Initial Statement of Beneficial Ownership (3)
September 14 2018 - 2:15PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Sandler Carl Forest Jr
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/6/2018
|
3. Issuer Name
and
Ticker or Trading Symbol
Enochian Biosciences Inc [ENOB]
|
(Last)
(First)
(Middle)
330 EAST 33RD STREET,, APARTMENT 3A
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__
X
__ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
NEW YORK, NY 10016
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
17545283
|
I
|
By Weird Science, LLC
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Options to purchase shares of common stock
(2)
|
2/28/2019
|
2/28/2028
|
Common Stock
|
7608
|
$8.00
|
D
|
|
Explanation of Responses:
|
(1)
|
On February 16, 2018, Weird Science acquired 17,545,283 shares of the Issuer's common stock. Mr. Sandler and W. Anderson Wittekind are each managers of Weird Science and share investment control over the shares held by Weird Science, LLC.
|
(2)
|
Mr. Sandler was appointed as a director on February 28, 2018. Mr. Sandler was granted options valued at $45,000 to purchase shares of the Issuer's common stock vesting annually over a three year period.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Sandler Carl Forest Jr
330 EAST 33RD STREET,
APARTMENT 3A
NEW YORK, NY 10016
|
X
|
X
|
|
|
William Anderson Wittekind
8581 SANTA MONICA BLVD
LOS ANGELES, CA 90069
|
|
X
|
|
|
Signatures
|
/s/ Carl Forest Sandler
|
|
9/14/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ W. Anderson Wittekind
|
|
9/14/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Enochian Biosciences (NASDAQ:ENOB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Enochian Biosciences (NASDAQ:ENOB)
Historical Stock Chart
From Apr 2023 to Apr 2024